piracetam has been researched along with memantine in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Gavrilova, SI; Zharikov, GA | 1 |
| Adler, G; Berger, FM; Calabrese, P; Frölich, L; Gertz, HJ; Hampel, H; Haupt, M; Jendroska, K; Kohler, J; Mielke, R; Paulus, HJ; Pilartz, H; Riepe, MW; Zedlick, D | 1 |
| Dudarova, MA; Iunishchenko, NA; Levin, OS | 1 |
| Dudarova, MA; Levin, OS; Yunishchenko, NA | 1 |
| Emelin, AIu; Litvinenko, IV; Lobzin, VIu; Vorob'ev, SV | 1 |
| Gelenli, E; Iseri, M; Topdag, DO; Topdag, M; Ulubil, SA; Ustundag, E; Yardimoglu, M; Yazir, Y | 1 |
| Pruitt, AA | 1 |
| Chou, YJ; Chow, LH; Hu, HY; Huang, N; Li, CP; Wang, PN; Wu, CY | 1 |
| Godley, A; Goetghebeur, PJ; Havolli, E; Hill, MD | 1 |
| Ahmed, AS; Al-Najjar, AH; Elgharabawy, RM | 1 |
| Andrade, C | 1 |
3 review(s) available for piracetam and memantine
| Article | Year |
|---|---|
[Current strategies of pathogenetic therapy of Alzheimer's disease].
Topics: Aged; Alzheimer Disease; Amino Acids; Aminoquinolines; Carbamates; Cholinesterase Inhibitors; Clinical Trials as Topic; Donepezil; Dopamine Agents; Estrogens; Ginkgo biloba; Humans; Indans; Memantine; Monoamine Oxidase Inhibitors; Multicenter Studies as Topic; Neuronal Plasticity; Neuroprotective Agents; Neurotransmitter Agents; Nicergoline; Nootropic Agents; Phenylcarbamates; Phytotherapy; Piperidines; Piracetam; Pyrithioxin; Rivastigmine; Selegiline; Tacrine; Time Factors | 2001 |
Medical management of patients with brain tumors.
Topics: Angiogenesis Inhibitors; Anticonvulsants; Brain Edema; Brain Neoplasms; Cognition Disorders; Dopamine Agents; Humans; Levetiracetam; Memantine; Palliative Care; Piracetam; Seizures | 2015 |
Reconsideration of the Benefits of Pharmacological Interventions for the Attenuation of the Cognitive Adverse Effects of Electroconvulsive Therapy.
Topics: Calcium Channel Blockers; Cholinesterase Inhibitors; Cognition; Electroconvulsive Therapy; Humans; Hydrocortisone; Ketamine; Melatonin; Memantine; Narcotic Antagonists; Nortriptyline; Pemoline; Piracetam; Treatment Outcome; Triiodothyronine; Tryptophan | 2022 |
3 trial(s) available for piracetam and memantine
| Article | Year |
|---|---|
[Efficacy of acatinol memantine in mild cognitive disorder].
Topics: Aged; Aged, 80 and over; Cognition; Cognition Disorders; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Female; Follow-Up Studies; Humans; Male; Memantine; Middle Aged; Neuroprotective Agents; Piracetam; Surveys and Questionnaires; Treatment Outcome | 2009 |
Efficacy of akatinol memantine in moderate cognitive impairments.
Topics: Aged; Aged, 80 and over; Cognition; Cognition Disorders; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Female; Follow-Up Studies; Humans; Male; Memantine; Middle Aged; Neuroprotective Agents; Piracetam; Surveys and Questionnaires; Treatment Outcome | 2010 |
[Clinical features of the formation and possibilities of treatment of posttraumatic cognitive disturbances].
Topics: Brain Injuries; Cognition Disorders; Excitatory Amino Acid Antagonists; Female; Humans; Magnetic Resonance Imaging; Male; Memantine; Nootropic Agents; Piracetam; Tomography, X-Ray Computed | 2010 |
6 other study(ies) available for piracetam and memantine
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
[Early diagnosis and treatment of Alzheimer's disease. Implementation in the doctor's office].
Topics: Aged; Alzheimer Disease; Brief Psychiatric Rating Scale; Carbamates; Cholinesterase Inhibitors; Dihydroergotoxine; Donepezil; Family Practice; Female; Follow-Up Studies; Galantamine; Ginkgo biloba; Humans; Indans; Male; Memantine; Neuroprotective Agents; Nimodipine; Nootropic Agents; Phenylcarbamates; Piperidines; Piracetam; Psychiatric Status Rating Scales; Risk Factors; Rivastigmine; Time Factors; Vasodilator Agents | 2002 |
Effect of intratympanic dexamethasone, memantine and piracetam on cellular apoptosis due to cisplatin ototoxicity.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cisplatin; Dexamethasone; Female; Labyrinth Diseases; Memantine; Piracetam; Rats; Rats, Wistar; Tympanic Membrane | 2012 |
The Effects of Anti-Dementia and Nootropic Treatments on the Mortality of Patients with Dementia: A Population-Based Cohort Study in Taiwan.
Topics: Cohort Studies; Dementia; Dihydroergocristine; Dihydroergotamine; Donepezil; Galantamine; Humans; Indans; Memantine; Neuroprotective Agents; Nootropic Agents; Piperidines; Piracetam; Proportional Hazards Models; Retrospective Studies; Rivastigmine; Taiwan; Time Factors | 2015 |
Spatial recognition test: A novel cognition task for assessing topographical memory in mice.
Topics: Alzheimer Disease; Animals; Cognition; Disease Models, Animal; Donepezil; Indans; Levetiracetam; Male; Maze Learning; Memantine; Memory; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nootropic Agents; Piperidines; Piracetam; Recognition, Psychology | 2017 |
Ameliorating effect of anti-Alzheimer's drugs on the bidirectional association between type 2 diabetes mellitus and Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Diabetes Mellitus, Type 2; Female; Humans; Male; Memantine; Middle Aged; Neuroprotective Agents; Piracetam; Treatment Outcome | 2017 |